CrossRef

Repurposing antiviral drugs against HTLV-1 protease by molecular docking and molecular dynamics simulation

Journal of Biomolecular Structure and Dynamics 41(11) (2023)

Hamidreza Jahantigh; Nahid Ahmadi; Piero Lovreglio; Angela Stufano; Maryam Enayatkhani; Behzad Shahbazi; Khadijeh Ahmadi

Dysregulation of immune gene expression profiles during HTLV-1 infection

Meta Gene 30 (2021)

Masoud Keikha; Mohammad Ali-Hassanzadeh; Ramin Bagheri; Mohsen Karbalaei

Untitled

Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities

Molecular Pharmaceutics 20(8) (2023)

Shivam Chowdhary; Rahul Deka; Kingshuk Panda; Rohit Kumar; Abhishikt David Solomon; Jimli Das; Supriya Kanoujiya; Ashish Kumar Gupta; Somya Sinha; Janne Ruokolainen; Kavindra Kumar Kesari; Piyush Kumar Gupta

New Perspectives about Drug Candidates Targeting HTLV-1 and Related Diseases

Pharmaceuticals 16(11) (2023)

Milena Cristina Martins da Silva; Renan Stefferson Barradas Pereira; Antonia Cherlly Aparecida Araujo; Ednilson Gregorio da Silva Filho; Anderson de Lima Dias; Kassio Silva Cavalcante; Maísa Silva de Sousa

Targeted Interventions in HAM/TSP: Emerging Therapies and Future Directions – A Narrative Review

Health Science Reports 9(8) (2026)

Meygol Mirzaei Rezaei; Mahdi Khosravi Nia; Kasra Allaei Rouzbahani; Maryam Kazemi; Negar Asghari Hosori; Mehdi Norouzi; Farzaneh Sotoudegan; Narges Eslami; Negar Ariamand; Vahid Shahnavaz; Arash Letafati; Sayed‑Hamidreza Mozhgani

Cloaked Viruses and Viral Factors in Cutting Edge Exosome-Based Therapies

Frontiers in Cell and Developmental Biology 8 (2020)

Christos Dogrammatzis; Hope Waisner; Maria Kalamvoki

Blockade of LIRs as a new approach for diagnostics and treatment of ATLL malignancy

Russian Journal of Infection and Immunity 11(6) (2021)

M. Keikha; M. Karbalaei

Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection

Microbial Pathogenesis 144 (2020)

Masoud Keikha; Kiarash Ghazvini; Majid Eslami; Bahman Yousefi; Jorge Casseb; Masoud Yousefi; Mohsen Karbalaei

Untitled

Multi-Complex Pharmacophore Mapping for the Repurposing of FDA Drugs as HTLV-1 Protease Inhibitors: Toward Novel Anti-HTLV-1 Therapeutics.

Biochemical and Biophysical Research Communications (2026)

Gurunathan RubhaShri; Sanjeev Kumar Singh